CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells

[1]  M. V. Recouvreux,et al.  Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer , 2017, Front. Endocrinol..

[2]  Jae Cheol Lee,et al.  Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines , 2017, Pancreas.

[3]  C. Wirtz,et al.  Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP , 2017, Oncotarget.

[4]  J. Xia,et al.  Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer , 2017, PloS one.

[5]  Y. Huang,et al.  Downregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients , 2017, Oncotarget.

[6]  David M. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[7]  O. Brady,et al.  Rags to riches: Amino acid sensing by the Rag GTPases in health and disease , 2016, Small GTPases.

[8]  Lijun Wang,et al.  Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo , 2016, Tumor Biology.

[9]  Bin Fan,et al.  Inhibition of mTOR signaling protects photoreceptor cells against serum deprivation by reducing oxidative stress and inducing G2/M cell cycle arrest , 2016, Molecular medicine reports.

[10]  D. Escobar,et al.  Rheb promotes cancer cell survival through p27Kip1‐dependent activation of autophagy , 2016, Molecular carcinogenesis.

[11]  C. Girardi,et al.  Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDB , 2015, BioMed research international.

[12]  K. Marcelain,et al.  Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelin-converting enzyme-1c protein stability , 2015, Oncotarget.

[13]  L. Cantley,et al.  Regulation of mTORC1 by PI3K signaling. , 2015, Trends in cell biology.

[14]  Jae Cheol Lee,et al.  AKT/mTOR down-regulation by CX-4945, a CK2 inhibitor, promotes apoptosis in chemorefractory non-small cell lung cancer cells. , 2015, Anticancer research.

[15]  Jean H. Overmeyer,et al.  Non-apoptotic cell death associated with perturbations of macropinocytosis , 2015, Front. Physiol..

[16]  Lei Wang,et al.  High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer. , 2015, Clinics and research in hepatology and gastroenterology.

[17]  A. Tee,et al.  mTOR and autophagy: a dynamic relationship governed by nutrients and energy. , 2014, Seminars in cell & developmental biology.

[18]  Pınar Obakan,et al.  Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells. , 2014, Experimental cell research.

[19]  A Vacca,et al.  Therapeutic targeting of the mTOR‐signalling pathway in cancer: benefits and limitations , 2014, British journal of pharmacology.

[20]  G. K. Gray,et al.  Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells , 2014, Oncotarget.

[21]  W. Maltese,et al.  Methuosis: nonapoptotic cell death associated with vacuolization of macropinosome and endosome compartments. , 2014, The American journal of pathology.

[22]  H. Liao,et al.  RAD001 enhances the radiosensitivity of SCC4 oral cancer cells by inducing cell cycle arrest at the G2/M checkpoint. , 2014, Anticancer Research.

[23]  Jiri Polivka,et al.  Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. , 2014, Pharmacology & therapeutics.

[24]  L. Cantley,et al.  Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome , 2014, Cell.

[25]  Kun-Liang Guan,et al.  Autophagy regulation by nutrient signaling , 2013, Cell Research.

[26]  Eric Lagasse,et al.  mTOR pathway in colorectal cancer: an update , 2013, Oncotarget.

[27]  E. Cuyás,et al.  Cell cycle regulation by the nutrient-sensing mammalian target of rapamycin (mTOR) pathway. , 2014, Methods in molecular biology.

[28]  M. Bredel,et al.  Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma , 2013, Clinical Cancer Research.

[29]  R. Lothe,et al.  Epigenetic and genetic features of 24 colon cancer cell lines , 2013, Oncogenesis.

[30]  M. Washington,et al.  mTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers , 2013, PLoS ONE.

[31]  A. Rajput,et al.  Restoration of PTEN activity decreases metastases in an orthotopic model of colon cancer. , 2010, The Journal of surgical research.

[32]  B. Guerra,et al.  Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells , 2012, International journal of oncology.

[33]  Adam Siddiqui-Jain,et al.  Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells. , 2012, Cancer letters.

[34]  Robert Clarke,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .

[35]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[36]  Liang Xu,et al.  Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. , 2012, American journal of cancer research.

[37]  P. Soares,et al.  The mTOR Signalling Pathway in Human Cancer , 2012, International journal of molecular sciences.

[38]  K. Marcelain,et al.  Protein kinase CK2 promotes cancer cell viability via up‐regulation of cyclooxygenase‐2 expression and enhanced prostaglandin E2 production , 2011, Journal of cellular biochemistry.

[39]  N. Nukina,et al.  Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. , 2011, Molecular cell.

[40]  M. Galindo,et al.  CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival , 2011, Molecular and Cellular Biochemistry.

[41]  M. Galindo,et al.  Phosphorylation of AKT/PKB by CK2 is necessary for the AKT‐dependent up‐regulation of β‐catenin transcriptional activity , 2011, Journal of cellular physiology.

[42]  Y. Dobashi,et al.  Mammalian target of rapamycin: a central node of complex signaling cascades. , 2011, International journal of clinical and experimental pathology.

[43]  W. Maltese,et al.  A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells , 2011, Molecular Cancer.

[44]  Chien-Feng Li,et al.  Overexpression of Nuclear Protein Kinase CK2 α Catalytic Subunit (CK2α) as a Poor Prognosticator in Human Colorectal Cancer , 2011, PloS one.

[45]  M. Demirci.  Comprehensive Clinical Nephrology 3rd Edition , 2011 .

[46]  B. Guerra,et al.  Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells , 2010, BMC Cancer.

[47]  R. Schneider,et al.  Mitotic Raptor Promotes mTORC1 Activity, G2/M Cell Cycle Progression, and Internal Ribosome Entry Site-Mediated mRNA Translation , 2010, Molecular and Cellular Biology.

[48]  Sara M. Johnson,et al.  Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. , 2010, Journal of the American College of Surgeons.

[49]  Chang Hwa Jung,et al.  mTOR regulation of autophagy , 2010, FEBS letters.

[50]  L. Pinna,et al.  Addiction to protein kinase CK2: a common denominator of diverse cancer cells? , 2010, Biochimica et biophysica acta.

[51]  Chien-Feng Li,et al.  Overexpression of Nuclear Protein Kinase CK2 β Subunit and Prognosis in Human Gastric Carcinoma , 2010, Annals of Surgical Oncology.

[52]  Massimo Libra,et al.  PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches , 2009, Cell cycle.

[53]  D. Litchfield,et al.  Protein Kinase CK2 in Health and Disease , 2009, Cellular and Molecular Life Sciences.

[54]  L. Pinna,et al.  Protein kinase CK2: An ugly duckling in the kinome pond , 2009 .

[55]  M. Bienz.  Faculty Opinions recommendation of Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice. , 2008 .

[56]  H. Lane,et al.  Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice , 2008, Proceedings of the National Academy of Sciences.

[57]  Erin E. Johnson,et al.  Active Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis , 2008, Molecular Cancer Research.

[58]  Robin Mathew,et al.  Role of autophagy in cancer , 2007, Nature Reviews Cancer.

[59]  D. Hallahan,et al.  Autophagy for Cancer Therapy through Inhibition of Pro-apoptotic Proteins and Mammalian Target of Rapamycin Signaling* , 2006, Journal of Biological Chemistry.

[60]  D. Rodriguez,et al.  Casein kinase 2 (CK2) increases survivin expression via enhanced β-catenin–T cell factor/lymphoid enhancer binding factor-dependent transcription , 2006, Proceedings of the National Academy of Sciences.

[61]  B. Guerra.  Protein kinase CK2 subunits are positive regulators of AKT kinase. , 2006, International journal of oncology.

[62]  L. Pinna,et al.  Protein kinase CK2 phosphorylates and upregulates Akt/PKB , 2005, Cell Death and Differentiation.

[63]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[64]  M. Hung,et al.  HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway* , 2000, The Journal of Biological Chemistry.

[65]  M. C. Hu,et al.  HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. , 2000, The Journal of biological chemistry.

[66]  K. Johnson.  An Update. , 1984, Journal of food protection.